scholarly journals Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Greece: a Cost Effectiveness Analysis Based on Clinical Trial and Real-World Data

2014 ◽  
Vol 17 (7) ◽  
pp. A597-A598
Author(s):  
V. Sonathi ◽  
M. Hatzikou ◽  
M. Baldwin ◽  
E. Panitti ◽  
E. Tzortzaki
Keyword(s):  
Clinical Trial ◽  
Economic Evaluation ◽  
Cost Effectiveness ◽  
Allergic Asthma ◽  
Real World ◽  
Standard Therapy ◽  
Cost Effectiveness Analysis ◽  
Real World Data ◽  
Effectiveness Analysis ◽  
Severe Allergic Asthma

scholarly journals Cost-Effectiveness Analysis of Omalizumab for Severe Allergic Asthma in Japan Using Real-World Evidence

2022 ◽  
Vol 27 ◽  
pp. 41-48
Author(s):  
Ataru Igarashi ◽  
Harneet Kaur ◽  
Abhay Choubey ◽  
Akshay Popli ◽  
Madhusubramanian Muthukumar ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Allergic Asthma ◽  
Real World ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Real World Evidence ◽  
Severe Allergic Asthma

scholarly journals Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study

2020 ◽  
Vol Volume 13 ◽  
pp. 43-53 ◽  
Author(s):  
Giorgio Walter Canonica ◽  
Giorgio Lorenzo Colombo ◽  
Paola Rogliani ◽  
Pierachille Santus ◽  
Claudia Pitotti ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Allergic Asthma ◽  
Cost Effectiveness Analysis ◽  
Asthma Treatment ◽  
Effectiveness Analysis ◽  
Severe Allergic Asthma
Sign in / Sign up

Export Citation Format

Share Document